The Sunday Read: ‘Podcasters Took Up Her Sister’s Murder Investigation. Then They Turned on Her’

After years of soaring optimism and colossal investment, Wall Street has begun to seriously question whether the frenzy for A.I. is justified.Cade Metz, who covers technology for The New York Times, explains why Silicon Valley companies believe so fervently in A.I. and why they’re willing to take enormous risks to deliver on its promise.Guest: Cade Metz, a technology reporter for The New York Times.Background reading: Why debt funding is ratcheting up the risks of the A.I. boom.Amazon, Google, Meta, Microsoft and OpenAI plan to spend at least $325 billion by the end of the year in pursuit of A.I.Photo: Scott Ball for The New York TimesFor more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

20 Nov 25min

Congressional Republicans on Tuesday overwhelmingly approved a bill to release all of the files related to the sex offender Jeffrey Epstein — a bill that President Trump spent months trying to kill.The Times correspondents Anni Karni and Carl Hulse explain how a rebellion started by a handful of Republican lawmakers became a partywide mutiny, and Representative Thomas Massie talks about his role in bringing about the vote.Guest:Annie Karni, a congressional correspondent at The New York Times.Carl Hulse, the chief Washington correspondent for The Times.Representative Thomas Massie, Republican of Kentucky.Background reading: The vote to approve was a stunning turn for an effort that Republican leaders had worked for months to block.For Mr. Trump, the Epstein scandal is the story that won’t go away.Photo: Tierney L. Cross/The New York TimesFor more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

19 Nov 33min

For the first time in 30 years, the annual U.N. conference on climate change is taking place without top government representation from the United States. China has emerged as the top dog at the summit and is poised to become the world’s supplier of green energy technology.David Gelles and Brad Plumer explain the growing showdown between global superpowers over the future of energy.Guest:David Gelles, a reporter on the New York Times climate team who leads The Times’s Climate Forward newsletter.Brad Plumer, a New York Times reporter based in Washington, covering technology and policy efforts to address global warming.Background reading: There’s a race to power the future. China is pulling away.At a climate summit without the U.S., allies and rivals call for action.Photo: Gilles Sabrie for The New York TimesFor more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

18 Nov 35min

When President Trump proposed the introduction of a 50-year mortgage, he challenged a bedrock of the American housing market and financial system. He also revealed how desperate the administration is to lower prices for consumers.Conor Dougherty, who covers housing and development, explains what’s attractive about the idea and its potential drawbacks — and why housing affordability is such an intractable problem.Guest: Conor Dougherty, a reporter for The New York Times covering housing and development for more than a decade.Background reading: The Trump administration is facing backlash from U.S. consumers as higher costs from tariffs blunt wage gains.Many Americans bought their first houses during the pandemic, when mortgage rates dipped to record lows. Now, some feel trapped.Photo: Joe Raedle/Getty ImagesFor more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

17 Nov 25min

There was once a time when documentaries could be found only on public television or in art-house cinemas. But today, documentaries are more popular and accessible than ever, with streaming services serving up true crime, celebrity documentaries, music documentaries and so much more.On today’s Sunday Special, Gilbert is joined by The New York Times’s chief television critic, James Poniewozik, and Alissa Wilkinson, a Times film critic, to talk about the documentaries that are worth your viewing time. On Today’s Episode:James Poniewozik is the chief TV critic for The Times.Alissa Wilkinson is a movie critic at The Times, and writes the Documentary Lens column. Background Reading:What ‘The American Revolution’ Says About Our Cultural Battles‘Come See Me in the Good Light’: The Sweetness After a Terminal Diagnosis  Discussed on this episode:“The American Revolution,” 2025, directed by Ken Burns, Sarah Botstein and David Schmidt“The Alabama Solution,” 2025, directed by Andrew Jarecki and Charlotte Kaufman“The Jinx: The Life and Deaths of Robert Durst,” 2015, directed by Andrew Jarecki“Making a Murderer,” 2015, directed by Laura Ricciardi and Moira Demos“The Yogurt Shop Murders,” 2025, directed by Margaret Brown“The Perfect Neighbor,” 2025, directed by Beet Gandbhir“The Last Dance,” 2020, directed by Jason Hehir“Copa 71,” 2023, directed by Rachel Ramsay and James Erkine“Cheer,” 2020, created by Greg Whiteley“Last Chance U,” 2016, directed by Greg Whiteley, Adam Ridley and Luke Lorentzen“Pee-wee as Himself,” 2025, directed by Matt Wolf“The Remarkable Life of Ibelin,” 2024, directed by Benjamin Ree“Ladies & Gentlemen … 50 Years of SNL Music,” 2025, directed by Questlove“Cameraperson,” 2016, directed by Kirsten Johnson“An American Family,” 1973, created by Craig Gilbert“Look Into My Eyes,” 2024, directed by Lana Wilson“When We Were Kings,” 1996, directed by Leon Gast Photo: Mike Doyle/American Revolution Film Project and Florentine Films Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

16 Nov 50min

The longtime editor and chronicler of the elite says she’s liberated and is letting it rip. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

15 Nov 48min

Drugs like Ozempic and Zepbound have revolutionized weight loss. And starting next year, the drugs are going to become more affordable for Americans because of a deal struck with pharmaceutical companies by the Trump administration.Eshe Nelson, who covers economics and business news, explains how the change has its origins in a huge business blunder from the creator of Ozempic, Novo Nordisk.Guest: Eshe Nelson, a reporter for The New York Times based in London, where she covers economics and business news.Background reading: How Ozempic’s maker lost its shine after creating a wonder drug.What Trump’s new drug pricing deal means for people with obesity.Photo: Sergei Gapon/Agence France-Presse — Getty ImagesFor more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

14 Nov 22min

Thousands of pages of newly released emails between Jeffrey Epstein and his associates have put the convicted sex offender’s relationship with President Trump back in the spotlight.David Enrich and Michael Gold, who have been covering the story, explain what the new documents tell us and discuss whether they could prompt the release of the rest of the Epstein files.Guest: David Enrich, a deputy investigations editor for The New York Times.Michael Gold, a congressional correspondent for The New York Times.Background reading: Mr. Trump said the Democrats were bringing up the Epstein “hoax” to deflect from the government shutdown.House Republicans asserted that the emails revealed little information.Photo: Doug Mills/The New York TimesFor more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

13 Nov 28min